![](https://lama2.com/wp-content/uploads/2020/11/T-UPF_CRG_Barcelona-AVENCIA-e1606774433950-640x320.jpg)
Dr. Avencia Sanchez-Mejías’ ex-vivo therapeutic approach to LAMA2-CMD
Dr. Avencia Sanchez-Mejías has been investigating how haematopoietic stem cells from LAMA2-CMD patients’ bone marrow, can be genetically corrected to…
Dr. Avencia Sanchez-Mejías has been investigating how haematopoietic stem cells from LAMA2-CMD patients’ bone marrow, can be genetically corrected to…
In the weekend from Friday the 15th to Sunday the 17th of November in 2019, we held the first international…
One of the specialists who will attend the conference is Dr. Dwi Kemaladewi. Together with an international team of scientists…
A key element in this endeavour is bringing all LAMA2-CMD researchers together in Maastricht in November for a 3-day conference.…